Abstract
Purpose
To evaluate the safety, efficacy, and the cost of combined phacoemulsification and single iStent insertion in open angle glaucoma (OAG) at 3-years follow-up.
Methods
This was a prospective, uncontrolled, interventional case series. All subjects underwent single iStent implantation combined with cataract surgery by a single surgeon and were followed up over 3 years. Primary outcome measures were the reduction in intraocular pressure (IOP) and number of glaucoma drops at 1, 2, and 3 years. The costs of the procedure vs the cost of continuation of glaucoma drops were calculated and compared in patients who completed 3-years follow-up.
Results
Forty-one patients were included in the study and thirty-six patients completed 3-years follow-up. Mean pre-op IOP was 21.2 mm Hg on 2.1 medications. Mean IOP was reduced to 15.9 mm Hg on 0.5 drops, 16.1 mm Hg on 1.0 drops, and 17.1 mm Hg (P<0.001) on 1.3 drops (P<0.001) at 1, 2, and 3 years, respectively. The overall cost of combined cataract surgery and iStent was estimated to be £829.32 more in total than conservative management with brand name eye drops over 3 years (£7.70 per patient per year) and £14 176.9 more if generic drops were used. (£131.3 per patient per year).
Conclusions
Combined phaco-iStent proved to be a safe and effective way of managing patients with OAG over our 3-year follow-up period. The cost-effectiveness of the procedure may vary depending on whether brand name or generic eye drops are used.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Patel I, de Klerk TA, Au L . Manchester iStent study: early results from a prospective UK case series. Clin Experiment Ophthalmol 2013; 41 (7): 648–652.
Platt R, Reardon G, Mozaffari E . Observed time between prescription refills for newer ocular hypotensive agents: the effect of bottle size. Am J Ophthalmol 2004; 137 (1 Suppl): S17–S23.
Malvankar-Mehta MS, Iordanous Y, Chen YN, Wang WW, Patel SS, Costella J et al. iStent with phacoemulsification versus phacoemulsification alone for patients with glaucoma and cataract: a meta-analysis. PLoS One 2015; 10 (7): e0131770.
Buchacra O, Duch S, Milla E, Stirbu O . One-year analysis of the iStent trabecular microbypass in secondary glaucoma. Clin Ophthalmol 2011; 5: 321–326.
Vandewalle E, Zeyen T, Stalmans I . The iStent trabecular micro-bypass stent: a case series. Bull Soc Belge Ophtalmol 2009; 311: 23–29.
Fea AM . Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma: randomized double-masked clinical trial. J Cataract Refract Surg 2010; 36 (3): 407–412.
Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE,, Group UiS. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 2011; 118 (3): 459–467.
Craven ER, Katz LJ, Wells JM, Giamporcaro JE,, Group iS. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg 2012; 38 (8): 1339–1345.
Arriola-Villalobos P, Martínez-de-la-Casa JM, Díaz-Valle D, Fernández-Pérez C, García-Sánchez J, García-Feijoó J . Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study. Br J Ophthalmol 2012; 96 (5): 645–649.
Belovay GW, Naqi A, Chan BJ, Rateb M, Ahmed II . Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma. J Cataract Refract Surg 2012; 38 (11): 1911–1917.
Spiegel D, García-Feijoó J, García-Sánchez J, Lamielle H . Coexistent primary open-angle glaucoma and cataract: preliminary analysis of treatment by cataract surgery and the iStent trabecular micro-bypass stent. Adv Ther 2008; 25 (5): 453–464.
Le K, Saheb H . iStent trabecular micro-bypass stent for open-angle glaucoma. Clin Ophthalmol 2014; 8: 1937–1945.
Improving quality and efficiency in the operating theatre. A lifeline for financial leaders: Institute for Innovation and Improvement; 2009. Available at http://harmfreecare.org/wp-content/files_mf/Improving-quality-and-efficiency-in-the-operating-theatre.pdf.
Painter SL, Mead AL . Patient experience of the transition from Xalatan to generic latanoprost. Eye 2014; 28 (7): 911.
Takada Y, Okada Y, Fujita N, Saika S . A patient with corneal epithelial disorder that developed after administration of a latanoprost generic, but not a brand-name drug, eye drop. Case Rep Ophthalmol Med 2012; 2012: 536746.
Iordanous Y, Kent JS, Hutnik CM, Malvankar-Mehta MS . Projected cost comparison of Trabectome, iStent, and endoscopic cyclophotocoagulation versus glaucoma medication in the Ontario Health Insurance Plan. J Glaucoma 2014; 23 (2): e112–e118.
Singh K, Lee BL, Wilson MR,, Group GMR-LM. A panel assessment of glaucoma management: modification of existing RAND-like methodology for consensus in ophthalmology. Part II: Results and interpretation. Am J Ophthalmol 2008; 145: 575–581.
Shaarawy T, Sherwood M, Grehn F . Guidelines on Design and Reporting of Glaucoma Surgical Trials. Kugler publications: Amsterdam, The Netherlands, 2009.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Tan, S., Au, L. Manchester iStent study: 3-year results and cost analysis. Eye 30, 1365–1370 (2016). https://doi.org/10.1038/eye.2016.139
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2016.139
This article is cited by
-
Endocyclophotocoagulation combined with phacoemulsification in surgically naive primary open-angle glaucoma: three-year results
Eye (2022)
-
A multicenter prospective comparative study evaluating cataract surgery and endoscopic cyclophotocoagulation either with or without iStent inject implantation in Brazilian patients with glaucoma
International Ophthalmology (2022)
-
Manchester iStent study: long-term 7-year outcomes
Eye (2021)
-
Second-generation trabecular micro-bypass stent implantation: Retrospective analysis after 12- and 24-month follow-up
Eye and Vision (2020)
-
12-Month Retrospective Comparison of Kahook Dual Blade Excisional Goniotomy with Istent Trabecular Bypass Device Implantation in Glaucomatous Eyes at the Time of Cataract Surgery
Advances in Therapy (2019)
